A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus
Clinical trial NCT01240694 · TERMINATED
Trial details
- NCT number
- NCT01240694
- Sponsor
- Cephalon, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-09
- Primary completion
- 2012-06-14
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.